These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16420942)

  • 21. The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver.
    Zhuang H; Sinha P; Pourdehnad M; Duarte PS; Yamamoto AJ; Alavi A
    Nucl Med Commun; 2000 Sep; 21(9):793-8. PubMed ID: 11065150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer.
    Beets G; Penninckx F; Schiepers C; Filez L; Mortelmans L; Kerremans R; Aerts R; De Roo M
    Br J Surg; 1994 Nov; 81(11):1666-70. PubMed ID: 7827902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET imaging for evaluation of metastatic colorectal cancer of the liver.
    Erturk SM; Ichikawa T; Fujii H; Yasuda S; Ros PR
    Eur J Radiol; 2006 May; 58(2):229-35. PubMed ID: 16457980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer.
    Lejeune C; Bismuth MJ; Conroy T; Zanni C; Bey P; Bedenne L; Faivre J; Arveux P; Guillemin F
    J Nucl Med; 2005 Dec; 46(12):2020-8. PubMed ID: 16330566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staging of colorectal cancer.
    Mehta S; Johnson RJ; Schofield PF
    Clin Radiol; 1994 Aug; 49(8):515-23. PubMed ID: 7955861
    [No Abstract]   [Full Text] [Related]  

  • 26. [Nuclear medical diagnostics for liver tumors].
    Buck AK; Stollfuss JC; Stahl A; Beer AJ; Meisetschläger G; Schwaiger M
    Internist (Berl); 2007 Jan; 48(1):21-4, 26-9. PubMed ID: 17195061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-volume vs. segmental CT texture analysis of the liver to assess metachronous colorectal liver metastases.
    Beckers RCJ; Beets-Tan RGH; Schnerr RS; Maas M; da Costa Andrade LA; Beets GL; Dejong CH; Houwers JB; Lambregts DMJ
    Abdom Radiol (NY); 2017 Nov; 42(11):2639-2645. PubMed ID: 28555265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography, computed tomography, and magnetic resonance imaging for the detection of experimental colorectal liver metastases.
    de Jong GM; Hendriks T; Bleichrodt RP; Dekker HM; Mus RD; Gotthardt M; Visser EP; Oyen WJ; Boerman OC
    Mol Imaging; 2012 Apr; 11(2):148-54. PubMed ID: 22469242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [F-18 fluorodeoxyglucose positron emission tomography in colorectal carcinoma].
    Jörg L; Langsteger W
    Wien Med Wochenschr; 2002; 152(11-12):276-9. PubMed ID: 12138655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controversies in the management of colorectal liver metastases: role of PET and PET/CT.
    Wiering B; Vogel WV; Ruers TJ; Oyen WJ
    Dig Surg; 2008; 25(6):413-20. PubMed ID: 19212113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver resection for colorectal metastases.
    Church R; Fleshman J; Dietz D; Strasberg S; Bramhall SR
    Ann R Coll Surg Engl; 2004 Sep; 86(5):401; author reply 401-2. PubMed ID: 15333184
    [No Abstract]   [Full Text] [Related]  

  • 32. Optimizing the role of FDG PET-CT for potentially operable metastatic colorectal cancer.
    Culverwell AD; Chowdhury FU; Scarsbrook AF
    Abdom Imaging; 2012 Dec; 37(6):1021-31. PubMed ID: 22371087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The computed tomography of colorectal tumors with water as the contrast medium].
    Gaa J; Deininger HK
    Rofo; 1990 Jun; 152(6):723-6. PubMed ID: 2163082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
    Abbadi RA; Sadat U; Jah A; Praseedom RK; Jamieson NV; Cheow HK; Whitley S; Ford HE; Wilson CB; Harper SJ; Huguet EL
    J Surg Oncol; 2014 Sep; 110(3):313-9. PubMed ID: 24737685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [CT arteriography together with portal venous CT in comparison with anti-CEA-immunoscintigraphy for the detection of liver metastases of colorectal cancer].
    Rilinger N; Friedrich JM; Pfeifer T; Tomczak R; Häberle J; Zeitler H; Waidelich HA; Niemann H
    Rontgenpraxis; 1992 Dec; 45(12):401-4. PubMed ID: 1492251
    [No Abstract]   [Full Text] [Related]  

  • 36. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.
    Abdel-Nabi H; Doerr RJ; Lamonica DM; Cronin VR; Galantowicz PJ; Carbone GM; Spaulding MB
    Radiology; 1998 Mar; 206(3):755-60. PubMed ID: 9494497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver resection for concomitant colorectal liver metastases and intrahepatic cholangiocarcinoma: a rare combination.
    Sotiropoulos GC; Tagkalos E; Kreft A; Moskalenko V; Gönner U; Molmenti EP; Timm S; Junginger T; Lang H
    Int J Colorectal Dis; 2009 Nov; 24(11):1349. PubMed ID: 19396452
    [No Abstract]   [Full Text] [Related]  

  • 38. The accuracy of computed tomography in the pretreatment staging of colorectal cancer.
    Tan YN; Li XF; Li JJ; Song YM; Jiang B; Yang J; Yuan Y
    Hepatogastroenterology; 2014; 61(133):1207-12. PubMed ID: 25436284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
    Donswijk ML; Hess S; Mulders T; Lam MG
    PET Clin; 2014 Oct; 9(4):421-41, v-vi. PubMed ID: 26050945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PET/CT: will it change the way that we use CT in cancer imaging?
    Hicks RJ; Ware RE; Lau EW
    Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.